| 5/28/2024 | BKHYIG | Moody's alters Qorvo outlook to positive
|
| 4/26/2024 | BK | Qorvo signs $325 million five-year revolver with BofA
|
| 6/28/2023 | BK | Qorvo adjusts covenants of $300 million revolving agreement
|
| 12/9/2021 | BKHYIG | Moody's gives Qorvo notes Ba1
|
| 12/9/2021 | BKHYIG | Fitch rates Qorvo notes BBB+
|
| 12/9/2021 | BKHYIG | S&P assigns Qorvo notes BBB-
|
| 8/3/2021 | BKIG | Fitch assigns Qorvo, notes BBB+
|
| 4/22/2021 | BKHYIG | S&P upgrades Qorvo
|
| 9/29/2020 | BK | Qorvo enters $300 million revolver, $200 million term loan
|
| 9/15/2020 | BKHY | Moody’s rates Qorvo notes Ba1
|
| 9/15/2020 | BKHY | S&P assigns Qorvo notes BB+
|
| 5/28/2020 | BKCVDDEMIGPV | Market Commentary: Six issuers price $3.57 billion; Macy’s, DaVita weaken; funds have record weekly inflow
|
| 12/17/2019 | BKCVDDEMIGPV | Market Commentary: Alliance Data, Bausch Health, Qorvo add-on price; Archrock in focus; oil patch firms
|
| 9/26/2019 | BKCVDDEMIGPV | Market Commentary: AMN drives by; Telesat joins slate; WeWork lower amid downgrade; Rite Aid better
|
| 9/25/2019 | BKCVDDEMIGPV | Market Commentary: Drive-by deals from Qorvo and Beacon; Howden prices; Inmarsat and BidFair/Sotheby’s active
|
| 9/25/2019 | BKHY | S&P rates Qorvo notes BB+
|
| 9/25/2019 | BKHY | Moody’s rates Qorvo incremental notes Ba1
|
| 6/25/2019 | BK | Qorvo extends delayed-draw availability period until December
|
| 2/28/2019 | BKCVDDEMIGPV | Market Commentary: Bombardier, CHS, Carter’s, Summit Materials, Qorvo price; PG&E active but flat
|
| 2/28/2019 | BKHY | Moody's rates Qorvo notes Ba1
|
| 1/3/2019 | BKCVDDEMIGPV | Market Commentary: No new deals in sight; trading volume light; Western Digital active; Qorvo drops; Teva up
|
| 8/14/2018 | BKCVDDEMIGPV | Market Commentary: CIT Group, Frontdoor, Denbury, Qorvo, Cogent price; Starwood on tap; Curo lags
|
| 8/14/2018 | BKHY | Moody’s: Qorvo unaffected by additional notes
|
| 7/12/2018 | BKCVDDEMIGPV | Market Commentary: Enterprise Development, goeasy price; Intelsat jumps; funds add $1.852 billion
|
| 7/11/2018 | BKCVDDEMIGPV | Market Commentary: European primary active; Transocean dominates; Simmons outperforms; Qorvo struggles
|
| 7/10/2018 | BKCVDDEMIGPV | Market Commentary: Transocean, DCP Midstream, Qorvo, Simmons Foods price; SFR Group active; Bombardier better
|
| 7/10/2018 | BKHY | Moody’s gives Ba1 to Qorvo notes
|
| 7/10/2018 | BKHY | S&P gives Qorvo notes BB+
|
| 12/6/2017 | BKHY | S&P gives Qorvo loan BB+
|
| 12/6/2017 | BK | Qorvo enters $300 million revolver, $400 million delayed-draw term loan
|
| 11/17/2015 | BKCVDDEMIGPV | Market Commentary: Ally, Rackspace, split-rated PBF deals price; Veritas out; Qorvo jumps; TerraForm falls
|
| 11/16/2015 | BKCVDDEMIGPV | Market Commentary: Week opens with quiet primary; Team Health stays strong; Qorvo, Sensata Technologies firm
|
| 11/13/2015 | BKCVDDEMIGPV | Market Commentary: Qorvo megadeal, Team Health close $3.7 billion week; new Team Health jumps; energy slide deepens
|
| 11/13/2015 | BK | Qorvo amends credit agreement covenants to allow for more debt
|
| 11/6/2015 | BKHY | S&P rates Qorvo CCR, notes, loan BB+
|
| 11/6/2015 | BKHY | Moody’s gives Qorvo CFR, notes Ba1
|
| 4/9/2015 | BK | Market Commentary: Bank loans higher; Science Applications talks $570 million; loan funds see miniscule outflow
|
| 4/9/2015 | BK | Qorvo gets $300 million five-year revolver at Libor plus 150 bps
|
| 3/30/2015 | BK | Qorvo expects to get larger revolver, terminates $125 million revolver
|
